Guo Rui-Xian, Zhao Yong-Kang, Hu Ke-Jian, Jia Kun-Mu, Shi Wei, Yi Yan-Xiao, Gong Hai-Ying, Wang Jia-Bo, Gao Yuan
School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Front Pharmacol. 2025 May 23;16:1544068. doi: 10.3389/fphar.2025.1544068. eCollection 2025.
Non-scarring alopecia, encompassing androgenetic alopecia (AGA), alopecia areata (AA), and telogen effluvium (TE), is a common skin condition that significantly impacts both the physical and psychological wellbeing of affected individuals. This review aims to delve into the multifactorial etiology of non-scarring alopecia and to critically assess the current and emerging treatment options available for management.
The review methodology involved a comprehensive literature search in PubMed and Web of Science, focusing on the genetic, environmental, and psychological factors that contribute to the development of non-scarring alopecia. The search included studies published from 2004 to 2024, primarily in English, to incorporate both foundational and recent advancements in the field. The inclusion criteria encompassed clinical trials, meta-analyses, and high-quality observational studies investigating the pathogenesis and treatment of non-scarring alopecia. Case reports, editorials, and studies with insufficient methodological details were excluded. Additionally, this review evaluated FDA-approved treatments (e.g., minoxidil and finasteride) and emerging therapeutic agents, such as Janus kinase (JAK) inhibitors and natural remedies, with an emphasis on their mechanisms, efficacy, and safety profiles.
The findings from this review indicate that the currently available treatments, such as topical and oral minoxidil, oral finasteride, and Janus kinase (JAK) inhibitors, exhibit limited efficacy and are associated with adverse effects. In contrast, natural remedies have shown promise as alternative treatments, potentially offering more effective management with fewer side effects.
The conclusion drawn from this review is that there is a significant potential for natural products and innovative drugs to provide effective treatment options for non-scarring alopecia. However, the assumption that natural remedies universally have fewer side effects than conventional treatments requires careful consideration, as their safety profiles vary. This underscores the need for further research and development in this area to improve patient outcomes and quality of life.
非瘢痕性脱发,包括雄激素性脱发(AGA)、斑秃(AA)和休止期脱发(TE),是一种常见的皮肤疾病,会对患者的身心健康产生重大影响。本综述旨在深入探讨非瘢痕性脱发的多因素病因,并严格评估当前及新兴的治疗方案。
综述方法包括在PubMed和Web of Science上进行全面的文献检索,重点关注导致非瘢痕性脱发发生的遗传、环境和心理因素。检索纳入了2004年至2024年发表的研究,主要为英文研究,以纳入该领域的基础研究和最新进展。纳入标准包括调查非瘢痕性脱发发病机制和治疗的临床试验、荟萃分析及高质量观察性研究。病例报告、社论以及方法学细节不足的研究被排除。此外,本综述评估了美国食品药品监督管理局(FDA)批准的治疗方法(如米诺地尔和非那雄胺)以及新兴治疗药物,如 Janus激酶(JAK)抑制剂和天然疗法,重点关注其作用机制、疗效和安全性。
本综述的结果表明,目前可用的治疗方法,如局部和口服米诺地尔、口服非那雄胺和Janus激酶(JAK)抑制剂,疗效有限且伴有不良反应。相比之下,天然疗法作为替代治疗方法显示出前景,可能提供更有效的治疗且副作用更少。
本综述得出的结论是,天然产品和创新药物有很大潜力为非瘢痕性脱发提供有效的治疗选择。然而,认为天然疗法普遍比传统治疗副作用更少的假设需要谨慎考虑,因为它们的安全性各不相同。这凸显了该领域进一步研发的必要性,以改善患者的治疗效果和生活质量。